Ives Drugs ( India).Ltd. Profile
Key Indicators
- Authorised Capital ₹ 4.80 Cr
- Paid Up Capital ₹ 3.20 Cr
- Company Age 38 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 38.01 Cr
- Satisfied Charges ₹ 10.09 Cr
- Revenue Growth 0.05%
- Profit Growth 139.46%
- Ebitda 504.50%
- Net Worth 293.84%
- Total Assets 6.94%
About Ives Drugs ( India).Ltd.
Ives Drugs ( India) Pvt.Ltd. (IDIP) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 April 1986 and has a history of 38 years and nine months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.80 Cr and a paid-up capital of Rs 3.20 Cr.
The company currently has active open charges totaling ₹38.01 Cr. The company has closed loans amounting to ₹10.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahendra Garg, Ramchandra Airen, Gaurav Airen, and Two other members serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232MP1986PTC003375
-
Company No.
003375
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Apr 1986
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Ives Drugs ( India).Ltd.?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitesh Dani
|
Director | 23-Mar-2021 | Current |
|
Mahendra Garg
|
Director | 17-Sep-1986 | Current |
|
Ramchandra Airen
|
Director | 17-Apr-1986 | Current |
|
Gaurav Airen
|
Director | 23-Mar-2021 | Current |
|
Satish Mangal
|
Director | 17-Sep-1986 | Current |
Financial Performance of Ives Drugs ( India).Ltd..
Ives Drugs ( India) Pvt.Ltd., for the financial year ended 2023, experienced modest growth in revenue, with a 0.05% increase. The company also saw a substantial improvement in profitability, with a 139.46% increase in profit. The company's net worth Soared by an impressive increase of 293.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ives Drugs ( India).Ltd.?
In 2023, Ives Drugs ( India).Ltd. had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dewas Metal Sections LimitedRamchandra Airen is a mutual person
-
Airen Cotton & Oil Mills Private LimitedRamchandra Airen is a mutual person
-
Airen International LimitedRamchandra Airen is a mutual person
-
Prem Pharmaceuticals Pvt LtdMahendra Garg, Gaurav Airen and 1 more are mutual person
-
Ives Leasing And Finance Limited
Ramchandra Airen, Gaurav Airen and 1 more are mutual person
-
Jai Kisan Agri Solution Private Limited
Ramchandra Airen is a mutual person
Charges (Loans)
₹38.01 Cr
₹10.09 Cr
Charges Breakdown by Lending Institutions
- City Union Bank Limited : 20.90 Cr
- Hdfc Bank Limited : 16.55 Cr
- Madhya Pradesh Financial Corporation : 0.45 Cr
- Others : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2023 | City Union Bank Limited | ₹0.09 M | Open |
| 18 Oct 2023 | Hdfc Bank Limited | ₹16.55 Cr | Open |
| 26 Oct 2018 | Others | ₹1.13 M | Open |
| 27 Jun 2011 | City Union Bank Limited | ₹20.89 Cr | Open |
| 02 May 1987 | Madhya Pradesh Financial Corporation | ₹1.00 M | Open |
How Many Employees Work at Ives Drugs ( India).Ltd.?
Ives Drugs ( India).Ltd. has a workforce of 213 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ives Drugs ( India).Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ives Drugs ( India).Ltd.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
